These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4841902)

  • 1. Salt preference in patients with untreated and treated essential hypertension.
    Schechter PJ; Horwitz D; Henkin RI
    Am J Med Sci; 1974 Jun; 267(6):320-6. PubMed ID: 4841902
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium chloride preference in essential hypertension.
    Schechter PJ; Horwitz D; Henkin RI
    JAMA; 1973 Sep; 225(11):1311-5. PubMed ID: 4740655
    [No Abstract]   [Full Text] [Related]  

  • 3. [Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension].
    de los Rios JC; Ortíz Feijoo J; Otero Cagide F
    Prensa Med Mex; 1976; 41(7-8):210-4. PubMed ID: 796845
    [No Abstract]   [Full Text] [Related]  

  • 4. Sodium detection threshold and preference for sodium chloride in humans on high and low sodium diets.
    DiNicolantonio R; Teow BH; Morgan TO
    Clin Exp Pharmacol Physiol; 1984; 11(4):335-8. PubMed ID: 6518662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt taste and hypertension: a critical review of the literature.
    Mattes RD
    J Chronic Dis; 1984; 37(3):195-208. PubMed ID: 6365942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taste responses to saltiness among hypertensive subjects under different therapeutic regimens.
    Little AC; Brinner LJ
    J Am Diet Assoc; 1985 May; 85(5):557-63. PubMed ID: 2859307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of haemodialysis on taste for salt in relation to changes in blood constituents.
    Farleigh CA; Shepherd R; Jevons S; Pryor JS
    Hum Nutr Clin Nutr; 1987 Nov; 41(6):441-51. PubMed ID: 3323141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rilmenidine on arterial pressure and urinary output in the spontaneously hypertensive rat.
    Cechetto DF; Kline RL
    Eur J Pharmacol; 1997 Apr; 325(1):47-55. PubMed ID: 9151938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased and decreased preference for saccharin immediately following injections of various agents.
    Kutscher CL; Yamamoto BK; Hamburger JN
    Physiol Behav; 1979 Sep; 23(3):461-4. PubMed ID: 504437
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats.
    Nariai T; Fujita K; Mori M; Katayama S; Hori S; Matsui K
    Pharmacology; 2012; 89(1-2):44-52. PubMed ID: 22302095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt taste and disease.
    Contreras RJ
    Am J Clin Nutr; 1978 Jun; 31(6):1088-97. PubMed ID: 352128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter regarding article by Hood et al, "The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio".
    Mulatero P; Milan A; Veglio F
    Circulation; 2008 Feb; 117(5):e151; author reply e152. PubMed ID: 18250276
    [No Abstract]   [Full Text] [Related]  

  • 13. Taste solution preferences of C57BL/6J and 129X1/SvJ mice: influence of age, sex, and diet.
    Tordoff MG
    Chem Senses; 2007 Sep; 32(7):655-71. PubMed ID: 17566070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of salt taste.
    Beauchamp GK; Bertino M; Engelman K
    Ann Intern Med; 1983 May; 98(5 Pt 2):763-9. PubMed ID: 6847015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of salt intake by choline chloride.
    Locke KW; Fielding S
    Physiol Behav; 1994 Jun; 55(6):1039-46. PubMed ID: 8047569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eplerenone.
    Brown R; Quirk J; Kirkpatrick P
    Nat Rev Drug Discov; 2003 Mar; 2(3):177-8. PubMed ID: 12619638
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing dietary salt alters salt taste preference.
    Bertino M; Beauchamp GK; Engelman K
    Physiol Behav; 1986; 38(2):203-13. PubMed ID: 3797487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
    Nair KG; Jairam HN; Lal HM; Phaterpekar SJ
    J Assoc Physicians India; 1980; 28(1-2):7-13. PubMed ID: 7216969
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a spironolactone and althiazide combination (aldactacine) in Africans with benign essential hypertension.
    Pinto JM
    East Afr Med J; 1981 Jan; 58(1):44-50. PubMed ID: 7011783
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of benign essential hypertension with an association of spironolactone and thiabutazide: an open multicenter study in general practice (author's transl)].
    Rhomberg F; Leya A
    Schweiz Rundsch Med Prax; 1981 Dec; 70(50):2269-78. PubMed ID: 7031639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.